BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38657793)

  • 1. Cardiovascular Outcomes of KCNJ5 Mutated Aldosterone-Producing Adenoma: A Systematic Review.
    Kato H; Kitamoto T; Kimura S; Sunouchi T; Hoshino Y; Hidaka N; Tsurutani Y; Ito N; Makita N; Nishikawa T; Nangaku M; Inoue K
    Endocr Pract; 2024 Apr; ():. PubMed ID: 38657793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype-genotype correlation in aldosterone-producing adenomas characterized by intracellular cholesterol metabolism.
    Harashima S; Yamazaki Y; Motomura N; Ono Y; Omata K; Tezuka Y; Morimoto R; Nakamura Y; Satoh F; Suzuki H; Kwon GE; Choi MH; Sasano H
    J Steroid Biochem Mol Biol; 2022 Jul; 221():106116. PubMed ID: 35533918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.
    Yamazaki Y; Omata K; Tezuka Y; Ono Y; Morimoto R; Adachi Y; Ise K; Nakamura Y; Gomez-Sanchez CE; Shibahara Y; Kitamoto T; Nishikawa T; Ito S; Satoh F; Sasano H
    Hypertension; 2018 Sep; 72(3):632-640. PubMed ID: 30354756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.
    Li X; Wang B; Tang L; Zhang Y; Chen L; Gu L; Zhang F; Ouyang J; Zhang X
    J Clin Endocrinol Metab; 2018 Mar; 103(3):813-823. PubMed ID: 29165597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and metabolic characters of
    Chang YY; Lee BC; Chen ZW; Tsai CH; Chang CC; Liao CW; Pan CT; Peng KY; Chou CH; Lu CC; Wu VC; Hung CS; Lin YH;
    Front Endocrinol (Lausanne); 2023; 14():1061704. PubMed ID: 36950676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone-producing adenoma-harbouring KCNJ5 mutations is associated with lower prevalence of metabolic disorders and abdominal obesity.
    Chen KM; Chang YL; Wu TH; Lee BC; Chen PT; Liu KL; Hong JS; Chang CC; Wu VC; Lin YH;
    J Hypertens; 2021 Dec; 39(12):2353-2360. PubMed ID: 34313632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma.
    Inoue K; Yamazaki Y; Kitamoto T; Hirose R; Saito J; Omura M; Sasano H; Nishikawa T
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3477-3485. PubMed ID: 30020487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
    Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
    Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics of the KCNJ5 mutated aldosterone-producing adenomas.
    Murakami M; Yoshimoto T; Nakabayashi K; Nakano Y; Fukaishi T; Tsuchiya K; Minami I; Bouchi R; Okamura K; Fujii Y; Hashimoto K; Hata KI; Kihara K; Ogawa Y
    Endocr Relat Cancer; 2017 Oct; 24(10):531-541. PubMed ID: 28747387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
    Oßwald A; Fischer E; Degenhart C; Quinkler M; Bidlingmaier M; Pallauf A; Lang K; Mussack T; Hallfeldt K; Beuschlein F; Reincke M
    Eur J Endocrinol; 2013 Nov; 169(5):657-63. PubMed ID: 23946277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations.
    Ono Y; Yamazaki Y; Omata K; Else T; Tomlins SA; Rhayem Y; Williams TA; Reincke M; Carling T; Monticone S; Mulatero P; Beuschlein F; Ito S; Satoh F; Rainey WE; Sasano H
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e282-9. PubMed ID: 31789380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
    Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T
    J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
    Gong S; Sun N; Meyer LS; Tetti M; Koupourtidou C; Krebs S; Masserdotti G; Blum H; Rainey WE; Reincke M; Walch A; Williams TA
    Hypertension; 2023 Jul; 80(7):1555-1567. PubMed ID: 37125608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
    Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
    Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Translationality of
    Kitamoto T; Nishikawa T
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Histopathological Characteristics of
    Mohideen SK; Mustangin M; Kamaruddin NA; Muhammad R; Jamal ARA; Sukor N; Tan GC; Azizan EA
    Front Endocrinol (Lausanne); 2019; 10():666. PubMed ID: 31636604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
    De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
    Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCNJ5 Mutation Contributes to Complete Clinical Success in Aldosterone-Producing Adenoma: A Study From a Single Center.
    Zhang C; Wu L; Jiang L; Su T; Zhou W; Zhong X; Xie J; Sun F; Zhu Y; Jiang Y; Wang W
    Endocr Pract; 2021 Jul; 27(7):736-742. PubMed ID: 33678553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.